Evidence map›Paper›PMID 23508173›Full record

ArticleNature chemical biology2013

Determining target engagement in living systems.

Gabriel M Simon, Micah J Niphakis, Benjamin F Cravatt

Abstract read
In one paragraph

Article in Nature chemical biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed.

  1. The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Target Engagement Assays in Early Drug Discovery.Journal of medicinal chemistry · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Theranostics · 2024
    Article
  20. Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gabriel M SimonAbide Therapeutics, San Diego, California, USA.
Micah J Niphakis
Benjamin F Cravatt

Funding

CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENTR01DA033760 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F, SCAMPAVIA, LOUIS DANIEL · 2012 to 2021
$5.1M
Chemical Probes for Metabolic Pathway Discovery in Human DiseaseR01CA132630 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2007 to 2018
$5.1M
Chemical Approaches for Activity-Based ProteomicsR37CA087660 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2009 to 2018
$3.1M
CHEMICAL APPROACHES FOR ACTIVITY BASED PROTEOMICSR01CA087660 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2000 to 2008
$2.8M
Chemical probes to assess endocannabinoid localization, storage, and transportF32DA032541 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI NIPHAKIS, MICAH JAMES · 2011 to 2013
$155k
NCI NIH HHS CA087660NCI NIH HHS CA132630NCI NIH HHS R01 CA087660NCI NIH HHS R01 CA132630NCI NIH HHS R37 CA087660NIDA NIH HHS DA032541NIDA NIH HHS DA033760NIDA NIH HHS F32 DA032541NIDA NIH HHS R01 DA033760
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Evaluation, PreclinicalAnimalsBiomarkers, PharmacologicalCell Culture TechniquesChromatography, LiquidHumansImmunoprecipitationMolecular ProbesMolecular Targeted TherapyProtein Array AnalysisRadiopharmaceuticalsTandem Mass SpectrometryValidation Studies as TopicBiomarkers, PharmacologicalMolecular ProbesRadiopharmaceuticals

Identifiers

PMID23508173
PMCPMC4004587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.